Form 8-K BRUKER CORP For: Feb 13

Go back to Form 8-K BRUKER CORP For: Feb 13

JPMorgan Upgrades Bruker (BRKR) to Overweight

February 13, 2024 4:24 PM EST

JPMorgan analyst Tycho W. Peterson upgraded Bruker (NASDAQ: BRKR) from Neutral to Overweight with a price target of $90.00 (from $60.00).

The analyst comments "This morning, Bruker (BRKR) reported a sizeable 4Q beat while initiating better-than-expected 2024 guidance and, most notably, pulled forward its 2026 revenue and non-GAAP EPS LRP targets to 2025 (implying >30% non-GAAP EPS growth in 2025). Strength across regions and end-markets is driven by secular trends in proteomics and other omics research in what the company describes as the... More